Table 2.

LOAECs specific for each DNT endpoint and their serial dilutions. These nominal concentrations (in μM) were used to prepare the three mixtures described in Materials and Methods.

	BPA	CPF	Lead	BDE-47	EtOH	Methyl-Hg	PCB-138	VA	Vincl	TCDD	(μM)
BDNF	12.74	37.10	1.46	0.20	106,810	0.13	3.53	210	0.42	0.60	LOAEC-bdnf
	6.37	18.55	0.73	0.10	53,405	0.07	1.77	105	0.21	0.30	LOAEC/2-bdnf
	3.19	9.28	0.37	0.05	26,703	0.03	0.88	52.5	0.11	0.15	LOAEC/4-bdnf
	1.59	4.64	0.18	0.02	13,351	0.017	0.44	26.25	0.05	0.08	LOAEC/8-bdnf
Neurite Outgrowth	12.74	37.1	1.46	0.20	170,000	0.13	11.86	420	5.31	0.04	LOAEC-neu
	6.37	18.55	0.73	0.10	85,000	0.07	5.93	210	2.66	0.02	LOAEC/2-neu
	3.19	9.28	0.37	0.05	42,500	0.03	2.97	105	1.33	0.01	LOAEC/4-neu
	1.59	4.64	0.18	0.02	21,250	0.016	1.48	52.5	0.66	0.005	LOAEC/8-neu
Synaptogenesis	12.74	21.01	0.0073	17.62	106,810	0.05	0.06	2.1	0.42	0.60	LOAEC-syn
	6.37	10.51	0.0037	8.81	53,405	0.025	0.03	1.05	0.21	0.30	LOAEC/2-syn
	3.19	5.25	0.0018	4.41	26,703	0.013	0.015	0.53	0.11	0.15	LOAEC/4-syn
	1.59	2.63	0.0009	2.20	13,351	0.006	0.0074	0.26	0.05	0.08	LOAEC/8-syn